Viewing Study NCT07070466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-07-22 @ 12:29 PM
Study NCT ID: NCT07070466
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-17
First Post: 2025-06-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Sponsor: Massachusetts General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stomach Cancer Stage IV View
None Esophagus Cancer View
None Stomach Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None esophageal cancer View
None stomach cancer View
None Phase 2 View
None Immunotherapy View